相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease
Ian F. Harrison et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synuclein
Susan R. Goulding et al.
PARKINSONISM & RELATED DISORDERS (2019)
BMP/SMAD Pathway Promotes Neurogenesis of Midbrain Dopaminergic Neurons In Vivo and in Human Induced Pluripotent and Neural Stem Cells
Vukasin M. Jovanovic et al.
JOURNAL OF NEUROSCIENCE (2018)
Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson's disease
Gerard W. O'Keeffe et al.
PARKINSONISM & RELATED DISORDERS (2018)
Gene co-expression analysis for functional classification and gene-disease predictions
Sipko van Dam et al.
BRIEFINGS IN BIOINFORMATICS (2018)
Nuclear Accumulation of Histone Deacetylase 4 (HDAC4) Exerts Neurotoxicity in Models of Parkinson's Disease
Qimei Wu et al.
MOLECULAR NEUROBIOLOGY (2017)
Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage
Isabel Paiva et al.
HUMAN MOLECULAR GENETICS (2017)
The SH-SY5Y cell line in Parkinson's disease research: a systematic review
Helena Xicoy et al.
MOLECULAR NEURODEGENERATION (2017)
HDAC5 and Its Target Gene, Npas4, Function in the Nucleus Accumbens to Regulate Cocaine-Conditioned Behaviors
Makoto Taniguchi et al.
NEURON (2017)
Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson's disease
Georgia Kouroupi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Nucleocytoplasmic Shuttling of Histone Deacetylase 9 Controls Activity-Dependent Thalamocortical Axon Branching
Ricardo Alchini et al.
SCIENTIFIC REPORTS (2017)
Zeb2 is a negative regulator of midbrain dopaminergic axon growth and target innervation
Shane V. Hegarty et al.
SCIENTIFIC REPORTS (2017)
The Epigenome as a therapeutic target for Parkinson's disease
Shane V. Hegarty et al.
NEURAL REGENERATION RESEARCH (2016)
Molecular Features Underlying Neurodegeneration Identified through In Vitro Modeling of Genetically Diverse Parkinson's Disease Patients
Lin Lin et al.
CELL REPORTS (2016)
Dach2-Hdac9 signaling regulates reinnervation of muscle endplates
Peter C. D. Macpherson et al.
DEVELOPMENT (2015)
Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells
L. M. A. Oliveira et al.
CELL DEATH & DISEASE (2015)
Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons
J. C. Koch et al.
CELL DEATH & DISEASE (2015)
Class IIa HDACs - new insights into their functions in physiology and pathology
Maribel Parra
FEBS JOURNAL (2015)
Class-IIa Histone Deacetylase Inhibition Promotes the Growth of Neural Processes and Protects Them Against Neurotoxic Insult
Louise M. Collins et al.
MOLECULAR NEUROBIOLOGY (2015)
HDAC Dependent Transcriptional Repression of Bmp-7 Potentiates TGF-β Mediated Renal Fibrosis in Obstructive Uropathy
Scott R. Manson et al.
JOURNAL OF UROLOGY (2014)
Genetic variability in the regulation of gene expression in ten regions of the human brain
Adaikalavan Ramasamy et al.
NATURE NEUROSCIENCE (2014)
Canonical BMP-Smad Signalling Promotes Neurite Growth in Rat Midbrain Dopaminergic Neurons
Shane V. Hegarty et al.
NEUROMOLECULAR MEDICINE (2014)
Injury-Induced HDAC5 Nuclear Export Is Essential for Axon Regeneration
Yongcheol Cho et al.
CELL (2013)
BMP2 and GDF5 induce neuronal differentiation through a Smad dependant pathway in a model of human midbrain dopaminergic neurons
Shane V. Hegarty et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2013)
The 3D Organization of the Yeast Genome Correlates with Co-Expression and Reflects Functional Relations between Genes
Dirar Homouz et al.
PLOS ONE (2013)
Epigenetic targeting of histone deacetylase: Therapeutic potential in Parkinson's disease?
Ian F. Harrison et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Distinct and overlapping gene regulatory networks in BMP- and HDAC-controlled cell fate determination in the embryonic forebrain
Catharina Scholl et al.
BMC GENOMICS (2012)
Toll-Like Signaling and the Cytokine IL-6 Regulate Histone Deacetylase Dependent Neuronal Survival
Nicole Forgione et al.
PLOS ONE (2012)
Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis
Maria M. Mihaylova et al.
CELL (2011)
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies
Michael A. Nalls et al.
LANCET (2011)
Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition
Sarah K. Kidd et al.
BRAIN RESEARCH (2010)
Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism
Paul B. Yui et al.
NATURE CHEMICAL BIOLOGY (2008)
Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease
Tiago Fleming Outeiro et al.
SCIENCE (2007)
α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity
Eirene Kontopoulos et al.
HUMAN MOLECULAR GENETICS (2006)
Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides
A Mai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
分享论文
